- SEK18.41bn
- SEK22.60bn
- SEK16.72bn
Brief: Elekta Delivers Record-High Cash Flow In Q3
Brief: Elekta Q3 Adjusted EBIT SEK 525 Million Vs. Estimate SEK 540 Million
Danske Bank resumes Elekta with 'buy' on pricing power, margins
Brief: Elekta, Bristol Myers Squibb Partner On Digital Solution For Patients With Melanoma
'Convalescence is over': Jefferies sees upbeat 2024 for European MedTech
Brief: Elekta Q2 Adjusted EBIT Up At SEK 542 Mln
Brief: Elekta Q2 EBIT at SEK 525 Million
Europe Research Roundup: Anglo American, Adevinta ASA, Auto Trader
Brief: Elekta Gets Order In India Worth USD 40 Million
Brief: Elekta Makes Acquisition Within Brachytherapy
Brief: Elekta Gets New Order In Ukraine
Top of the Street: Elekta, Straumann, Banco BPM, European beverages
Barclays starts Elekta with "underperform" citing risks to medium-term growth
Q1 sales, margin beat boosts Elekta shares
Brief: Elekta Q1 EBIT at SEK 412 Million
Brief: Elekta Expects Inflationary Pressure To Continue
Top of the Street: Pharma, healthcare, Tryg, Campari, Bunzl
GS sees brighter outlook for European medical technology companies
Europe Research Roundup: Aegon, Oxford Nanopore Technologies, United Utilities